HEIDELBERG, Germany, Nov 17 (Bernama-PRNewswire) — European Wellness Academy (EWA), a member of European Wellness Biomedical Group (EWBG), recently signed its second research contract involving General In Vitro/In Vivo Safety and Toxicity Tests for Preclinical Studies of Regenerative Peptides with Heidelberg University.
The research contract signed is a continuation of the previous research on the efficacy of the Group’s cutting-edge biotherapeutics including precursor (progenitor) stem cells (PSC), precursor cells (Frozen Organo Crygenics (FOC)), Mito Organelles (MO), Nano Organo Peptides (NOP) and exosomes.
- Israel Launches Airstrikes On Eastern, Southern Lebanon
- Houthis Vow Continued Attacks On Israel
- US: Pres Trump threatens extra 10% tariff on nations that side with BRICS
- Empowering youth in agriculture could boost global economy, FAO report says
- BRICS Summit: Colombia, Uzbekistan join BRICS Bank
- S. Korea’s Special Counsel Seeks Warrant To Detain Ex-President Yoon
- Bangladesh Ready To Cooperate With Malaysia In Terror Investigation
- Iran’s Supreme Leader Attended Mourning Ceremony In Tehran
- 45 Opposition Party Members In Türkiye’s Izmir Arrested On Corruption Charges
- Iran Reaffirms Commitment To Diplomacy, Urges Reciprocal Action